You feel the urge to go, but nothing comes out. Or you strain for minutes, only to trickle. That's underactive bladder (UAB), and it's more common than you think — especially in older adults. The underactive bladder market report by MRFR shows that pharmacological treatments are the largest segment, but non‑pharmacological treatments are the fastest‑growing. The market is $4.13 billion and will hit $8.42 billion by 2035, growing at 6.69% CAGR. Why the surge? Because we're finally talking about bladder health without embarrassment.

What's driving growth? Hospitals are the largest end‑user segment, but homecare settings are the fastest‑growing. The underactive bladder market analysis highlights that overactive bladder medications are the largest category, but neuromodulation devices are the fastest‑growing — as patients seek drug‑free options.

What's new? Sacral neuromodulation (InterStim) and percutaneous tibial nerve stimulation (PTNS) are changing lives. Also, smartphone‑connected bladder diaries that track voiding patterns.

The bottom line: if you struggle to empty your bladder, don't suffer in silence. See a urologist. There are more options than ever.